Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

EDI Enhancement

Active
2011-EDI-96652Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Centers for Disease Control and Prevention (CDC) intends to issue a sole source purchase order to GlaxoSmithKline (GSK) for the development of a real-time or near real-time electronic data interface between GSK and the CDC Vaccine Tracking System (VTrcKS). This interface will utilize established industry-standard messaging formats, methodologies, and technologies already in use within the CDC to enhance data exchange efficiency and accuracy. The contract aims to improve the electronic data interchange capabilities for vaccine tracking by leveraging GSK's expertise and existing technological frameworks. This acquisition is not open for competitive proposals and does not constitute a solicitation. The purpose is to streamline and facilitate timely data transmission between the CDC and GSK, ensuring more efficient vaccine monitoring and management. Questions or concerns regarding this notice are directed to the CDC contact Cherie J. Katin via email. The contract is referenced under the solicitation number 2011-EDI-96652 and is categorized under NAICS code 325414, which pertains to pharmaceutical preparation manufacturing.

General Info

CDC awards sole source contract to GSK for real-time electronic vaccine data interface development.

Agency

N/A

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

KTR location, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Cherie J. Katin

Full Description

Show more
2011-EDI-96652 The Centers for Disease Control and Prevention (CDC), contemplates issuing a sole source purchase order to GlaxoSmithKline (GSK) for their design of a real-time or near real-time electronic data interface between GSK and the CDC Vaccine Tracking System (VTrcKS) utilizing existing industry standard messaging formats, methodologies and technologies within CDC This is not a request for competitive proposals, nor is a solicitation available. All questions/concerns about this notice shall be submitted via e-mail to Ckatin@cdc.gov

Similar Contracts

Same NAICS industry code

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

21 days ago

DEADLINE

in 20 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS